Preoperative predictors of blood transfusion in colorectal cancer surgery

Kent R. Nilsson, Sean Berenholtz, Todd Dorman, Elizabeth Garrett, Pamela A Lipsett, Howard S. Kaujman, Peter J. Pronovost

Research output: Contribution to journalArticle

Abstract

Transfusion is associated with multiple risks and morbidities. Little is known, however, about preoperative predictors of transfusion in gastrointestinal surgery patients. To identify factors that influence transfusion practices, we analyzed hospital discharge data from colorectal cancer surgery patients in Maryland between 1994 and 2000 (n = 14,052). The primary outcome variable was whether or not patients received a blood product ("Any Transfusion"). Characteristics independently associated with an increased risk of receiving Any Transfusion included: advanced age (>80 yr: OR 2.3; 95% CI 1.9-2.9; 70-79 yr: OR 1.6; 95% CI 1.4-2.0 vs. 12 cases/yr) were at a decreased risk (OR 0.8; 95% CI 0.6-0.99). The association between greater surgeon case volume and low transfusion rates was seen in all but the very high volume hospitals (>74 cases/yr). Blood product transfusion was associated with a 2.5-fold (95% CI 2.1-3.1) increased mortality, 3.7 day (95% CI 2.1-3.1) increase in hospital length of stay, and a $7120 (95% CI $6472-$7769) increase in total charges compared to patients that did not receive Any Transfusion. This data can be used by providers in discussions with patients regarding the risks for transfusion and in identifying patients in whom strategies to reduce transfusions should be evaluated.

Original languageEnglish (US)
Pages (from-to)753-762
Number of pages10
JournalJournal of Gastrointestinal Surgery
Volume6
Issue number5
DOIs
StatePublished - 2002

Fingerprint

Colorectal Surgery
Blood Transfusion
Colorectal Neoplasms
Length of Stay
High-Volume Hospitals
Morbidity
Mortality

Keywords

  • Blood transfusion
  • Colorectal cancer
  • Outcomes

ASJC Scopus subject areas

  • Surgery

Cite this

Preoperative predictors of blood transfusion in colorectal cancer surgery. / Nilsson, Kent R.; Berenholtz, Sean; Dorman, Todd; Garrett, Elizabeth; Lipsett, Pamela A; Kaujman, Howard S.; Pronovost, Peter J.

In: Journal of Gastrointestinal Surgery, Vol. 6, No. 5, 2002, p. 753-762.

Research output: Contribution to journalArticle

Nilsson, Kent R. ; Berenholtz, Sean ; Dorman, Todd ; Garrett, Elizabeth ; Lipsett, Pamela A ; Kaujman, Howard S. ; Pronovost, Peter J. / Preoperative predictors of blood transfusion in colorectal cancer surgery. In: Journal of Gastrointestinal Surgery. 2002 ; Vol. 6, No. 5. pp. 753-762.
@article{d2d903d3ba5e4b04b18f51f08c46edc5,
title = "Preoperative predictors of blood transfusion in colorectal cancer surgery",
abstract = "Transfusion is associated with multiple risks and morbidities. Little is known, however, about preoperative predictors of transfusion in gastrointestinal surgery patients. To identify factors that influence transfusion practices, we analyzed hospital discharge data from colorectal cancer surgery patients in Maryland between 1994 and 2000 (n = 14,052). The primary outcome variable was whether or not patients received a blood product ({"}Any Transfusion{"}). Characteristics independently associated with an increased risk of receiving Any Transfusion included: advanced age (>80 yr: OR 2.3; 95{\%} CI 1.9-2.9; 70-79 yr: OR 1.6; 95{\%} CI 1.4-2.0 vs. 12 cases/yr) were at a decreased risk (OR 0.8; 95{\%} CI 0.6-0.99). The association between greater surgeon case volume and low transfusion rates was seen in all but the very high volume hospitals (>74 cases/yr). Blood product transfusion was associated with a 2.5-fold (95{\%} CI 2.1-3.1) increased mortality, 3.7 day (95{\%} CI 2.1-3.1) increase in hospital length of stay, and a $7120 (95{\%} CI $6472-$7769) increase in total charges compared to patients that did not receive Any Transfusion. This data can be used by providers in discussions with patients regarding the risks for transfusion and in identifying patients in whom strategies to reduce transfusions should be evaluated.",
keywords = "Blood transfusion, Colorectal cancer, Outcomes",
author = "Nilsson, {Kent R.} and Sean Berenholtz and Todd Dorman and Elizabeth Garrett and Lipsett, {Pamela A} and Kaujman, {Howard S.} and Pronovost, {Peter J.}",
year = "2002",
doi = "10.1016/S1091-255X(02)00043-4",
language = "English (US)",
volume = "6",
pages = "753--762",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Preoperative predictors of blood transfusion in colorectal cancer surgery

AU - Nilsson, Kent R.

AU - Berenholtz, Sean

AU - Dorman, Todd

AU - Garrett, Elizabeth

AU - Lipsett, Pamela A

AU - Kaujman, Howard S.

AU - Pronovost, Peter J.

PY - 2002

Y1 - 2002

N2 - Transfusion is associated with multiple risks and morbidities. Little is known, however, about preoperative predictors of transfusion in gastrointestinal surgery patients. To identify factors that influence transfusion practices, we analyzed hospital discharge data from colorectal cancer surgery patients in Maryland between 1994 and 2000 (n = 14,052). The primary outcome variable was whether or not patients received a blood product ("Any Transfusion"). Characteristics independently associated with an increased risk of receiving Any Transfusion included: advanced age (>80 yr: OR 2.3; 95% CI 1.9-2.9; 70-79 yr: OR 1.6; 95% CI 1.4-2.0 vs. 12 cases/yr) were at a decreased risk (OR 0.8; 95% CI 0.6-0.99). The association between greater surgeon case volume and low transfusion rates was seen in all but the very high volume hospitals (>74 cases/yr). Blood product transfusion was associated with a 2.5-fold (95% CI 2.1-3.1) increased mortality, 3.7 day (95% CI 2.1-3.1) increase in hospital length of stay, and a $7120 (95% CI $6472-$7769) increase in total charges compared to patients that did not receive Any Transfusion. This data can be used by providers in discussions with patients regarding the risks for transfusion and in identifying patients in whom strategies to reduce transfusions should be evaluated.

AB - Transfusion is associated with multiple risks and morbidities. Little is known, however, about preoperative predictors of transfusion in gastrointestinal surgery patients. To identify factors that influence transfusion practices, we analyzed hospital discharge data from colorectal cancer surgery patients in Maryland between 1994 and 2000 (n = 14,052). The primary outcome variable was whether or not patients received a blood product ("Any Transfusion"). Characteristics independently associated with an increased risk of receiving Any Transfusion included: advanced age (>80 yr: OR 2.3; 95% CI 1.9-2.9; 70-79 yr: OR 1.6; 95% CI 1.4-2.0 vs. 12 cases/yr) were at a decreased risk (OR 0.8; 95% CI 0.6-0.99). The association between greater surgeon case volume and low transfusion rates was seen in all but the very high volume hospitals (>74 cases/yr). Blood product transfusion was associated with a 2.5-fold (95% CI 2.1-3.1) increased mortality, 3.7 day (95% CI 2.1-3.1) increase in hospital length of stay, and a $7120 (95% CI $6472-$7769) increase in total charges compared to patients that did not receive Any Transfusion. This data can be used by providers in discussions with patients regarding the risks for transfusion and in identifying patients in whom strategies to reduce transfusions should be evaluated.

KW - Blood transfusion

KW - Colorectal cancer

KW - Outcomes

UR - http://www.scopus.com/inward/record.url?scp=0036717116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036717116&partnerID=8YFLogxK

U2 - 10.1016/S1091-255X(02)00043-4

DO - 10.1016/S1091-255X(02)00043-4

M3 - Article

C2 - 12399066

AN - SCOPUS:0036717116

VL - 6

SP - 753

EP - 762

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 5

ER -